Aigen Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,647
| Closed | -$224K | – | 927 |
|
|
2023
Q4 | $224K | Sell |
6,647
-4,044
| -38% | -$136K | 0.04% | 620 |
|
|
2023
Q3 | $328K | Buy |
+10,691
| New | +$328K | 0.06% | 492 |
|
|
2020
Q4 | – | Sell |
-46,582
| Closed | -$2.8M | – | 976 |
|
|
2020
Q3 | $2.8M | Buy |
46,582
+15,939
| +52% | +$958K | 0.36% | 63 |
|
|
2020
Q2 | $1.61M | Sell |
30,643
-9,243
| -23% | -$485K | 0.21% | 135 |
|
|
2020
Q1 | $1.34M | Buy |
39,886
+39,832
| +73,763% | +$1.34M | 0.18% | 154 |
|
|
2019
Q4 | $2K | Buy |
+54
| New | +$2K | ﹤0.01% | 1051 |
|